about
Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive ratsAntioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculationNitric oxide-releasing non steroidal anti-inflammatory drugs: a new generation of anti-tumoral moleculesCooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherenceEnhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaBPositional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivoNCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigsVascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitusNitric oxide-releasing drugs: a novel class of effective and safe therapeutic agentsNCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail arteryNitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effectGastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic studyNitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirinNitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemiaNSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives
P50
Q28165464-B3F72D24-B9B2-4A86-B4E5-509F9204658FQ28165690-C3F975BD-E8A7-4977-B9E3-84ECB6F0A08CQ28166547-F752890A-7E11-4DD6-8B5D-E7D4B50AAD82Q28167148-65F4480A-B6EF-4E76-A7E7-B3B351B98CAFQ28168528-F36CD2E4-583D-43E6-9FFB-C51EDC6BF774Q28171418-2679A585-7EE5-475F-8C2E-96A0DFD6939DQ28192821-37F83818-65A7-456E-9191-D66915FA6915Q28193073-C733B602-BF9E-4ACD-A5A5-097F8DAD1514Q28193259-559C617F-C817-49F8-8EF7-47D661751768Q28193679-BFF87BA3-39DB-43F9-8D6B-438699931888Q28194248-9B460B1A-88B6-4854-9306-255C42422599Q28195152-578516C5-9AF7-41CB-9F5B-50C2911BC537Q28196083-537BB2D3-8697-4C28-BAC5-766784C68FD6Q28212207-5DDB88F4-8D7B-41A8-8CCB-469E2EB96DC0Q28214007-7F6BDA2D-B8F6-4317-BD43-6AB4A139C3D4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Piero Del Soldato
@ast
Piero Del Soldato
@en
Piero Del Soldato
@es
Piero Del Soldato
@nl
Piero Del Soldato
@sl
type
label
Piero Del Soldato
@ast
Piero Del Soldato
@en
Piero Del Soldato
@es
Piero Del Soldato
@nl
Piero Del Soldato
@sl
prefLabel
Piero Del Soldato
@ast
Piero Del Soldato
@en
Piero Del Soldato
@es
Piero Del Soldato
@nl
Piero Del Soldato
@sl